£2.0M
The pre-series a financing was led by Science Angel Syndicate and Fink Family Office to support pre-clinical studies for the GRACE implant.
Science Angel Syndicate sources scientific discoveries and provides due diligence to help members invest in research-led technologies.
Portfolio
2
companies

QV Bioelectronics
QV Bioelectronics builds surgically implanted electric field therapy devices to treat brain tumours.
Transdermal Diagnostics
Transdermal Diagnostics develops a needle-free platform for continuous blood sugar monitoring.
The pre-series a financing was led by Science Angel Syndicate and Fink Family Office to support pre-clinical studies for the GRACE implant.
The pre-seed round was led by QUBIS Innovation Fund and will support clinical trial preparations and engineering hires.
"We are delighted to have led this investment round into Transdermal Diagnostics. The transdermal approach for glucose monitoring that Transdermal Diagnostics is developing will have a disruptive impact on the diabetes market, we are additionally excited by the company’ potential to expand into the wellness and sports nutrition industries. This funding round alongside the Innovate UK funding will help support them in this journey."